U.S. market Closed. Opens in 43 minutes

FLXN | Flexion Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue85.55M72.96M22.52M355.00KN/AN/AN/AN/AN/AN/A
Cost of Revenue19.25M9.96M7.34M4.00KN/AN/AN/AN/AN/AN/A
Gross Profit66.30M63.00M15.19M351.00KN/AN/AN/AN/AN/AN/A
Operating Expenses159.32M199.27M174.39M130.03M69.78M46.06M26.99M17.77M15.01M11.29M
Selling, General & Admin105.00M129.71M121.31M78.80M28.47M13.37M9.06M6.70M3.95M3.05M
Research & Development54.33M69.56M53.08M51.23M41.31M32.69M17.92M11.06M11.07M8.24M
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-93.02M-136.27M-159.20M-129.68M-69.78M-46.06M-26.99M-17.77M-15.01M-11.29M
Other Expenses / Income-20.19M-13.50M-10.46M-7.80M-2.11M-252.38K-326.39K-421.51K30.02K-159.38K
Before Tax Income-113.21M-149.77M-169.66M-137.48M-71.89M-46.32M-27.31M-18.19M-14.98M-11.45M
Income Tax Expenses495.00K3.56M5.25M3.47M-366.48K318.62K74.98K27.37K30.02K-159.38K
Net Income-113.71M-149.77M-169.66M-137.48M-71.89M-46.32M-27.31M-18.19M-14.98M-11.45M
Interest Expenses20.03M17.07M15.71M11.27M1.75M570.99K401.37K448.89KN/AN/A
Basic Shares Outstanding42.78M38.09M37.75M33.03M25.30M21.50M13.89M14.75M7.34M9.74M
Diluted Shares Outstanding42.78M38.09M37.75M33.03M25.30M21.50M13.89M14.75M7.34M9.74M
EBITDA-89.84M-130.31M-152.23M-124.20M-69.00M-45.51M-26.79M-17.66M-14.94M-11.34M
EBITDA Margin-105.01%-178.61%-675.87%-34,987.32%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-93.18M-129.14M-148.69M-122.75M-70.51M-45.43M-26.84M-17.71M-14.95M-11.61M
EBIT Margin-108.92%-177.01%-660.15%-34,576.06%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙